Revises telehealth and telemedicine requirements concerning adult prescription of certain Schedule II drugs for treatment of attention-deficit/hyperactivity disorder.
Introduced First Reading Assembly Referred to AHE
Email me when A 5534 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track A 5534. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
A5534 updates New Jersey's telehealth and telemedicine requirements for adult patients who receive specific Schedule II medications for attention‑deficit/hyperactivity disorder. The changes would affect doctors, telehealth providers, and adult patients using remote services to obtain ADHD treatment. The revision aims to clarify how these controlled substances can be prescribed via telemedicine.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about A 5534
3 free questions a day, no accountSponsors
- Anthony Verrelli (D) · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when A 5534 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track A 5534 freeOr ask your AI assistant about A 5534 directly:
Add to Claude, ChatGPT or Cursor